Results 211 to 220 of about 199,652 (389)

New insights into applications of base editor in hereditary disorders

Interdisciplinary Medicine, EarlyView.
Abstract Hereditary disorders are a group of diseases caused by genetic mutations or chromosomal variations. Although the incidence of each genetic disorder is relatively low, patients affected by the disease generally experience a range of severe symptoms, including blindness, disability, and even premature death. In addition, the available treatments
Maoping Cai, Linhui Zhang, Liqing Li, Yue Liu, Canbin Lv, Yan Shi, Jianyuan Zhao, Dingwei Ye, Yuanyuan Qu   +8 more
wiley   +1 more source

Association of Interferon‐ and Transforming Growth Factor β–Regulated Genes and Macrophage Activation With Systemic Sclerosis–Related Progressive Lung Fibrosis

Arthritis & Rheumatology, 2014
R. Christmann, P. Sampaio-Barros, Giuseppina Stifano, C. Borges, Carlos R. Carvalho, R. Kairalla, E. Parra, A. Spira, R. Simms, V. Capellozzi, R. Lafyatis   +10 more
semanticscholar   +1 more source

Rapidly progressive systemic sclerosis with a fatal outcome in male patients

Rheumatology, 2010
Objectives: Retrospective analysis of clinical outcomes of malepatients with particularly severe and rapidly progressive diffusesystemic sclerosis (SSc) with a fatal outcome with emphasis onorgan involvement and results of diagnostic tests, and ...
Małgorzata Widuchowska, Maria Głowacka, Magdalena Kopeć-Mędrek, Anna Kotulska, Marzena Trzaska-Sobczak, Eugeniusz J. Kucharz   +5 more
doaj  

Alterations of glomerular filtration rate during cold exposure in progressive systemic sclerosis: Measurement with technetium-99m DTPA.

, 1990
Kunihiko Yamauchi, S Arimori
openalex   +2 more sources

Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan

Movement Disorders Clinical Practice, EarlyView.
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori, Yohei Mukai, Noriko Nishikawa, Kazuko Hasegawa, Masahiko Tomiyama, Yasuyoshi Kimura, Yoshio Tsuboi, Ryosuke Takahashi, Ryota Nakamura, Yuishin Izumi, Hirohisa Watanabe, Morinobu Seki, Kenji Sekiguchi, Shohei Tateishi, Yusaku Matsushita, Yusaku Nakamura   +15 more
wiley   +1 more source

Progressive Systemic Sclerosis Complicated with Primary Cerebral Malignant Lymphoma.

, 1994
Atsushi Suzuki, Hitomi Ohoike, Yasuhisa Kitagawa, Yasuo Matsuoka, Shoichiro Irimajiri   +4 more
openalex   +2 more sources

Global Disease Burden of Immune‐Mediated Inflammatory Diseases (IMIDs), 1990–2021

Med Research, EarlyView.
This study provides the first standardized evaluation of the direct health burden of inflammatory and immune‐mediated diseases (IMIDs) across 231 locations worldwide from 1990 to 2021, spanning five geographic levels: global, SDI regions, GBD regions, countries, and territories.
Xueping Zhu, Mengli Yue, Xu Zhang, Yuanxia Han, Rui Xia, Qingwei Zhang, Yize Mao, Xin Guan   +7 more
wiley   +1 more source

Progressive Systemic Sclerosis

International Journal of Clinical Practice, 1964
openaire   +2 more sources

Progressive systemic sclerosis(PSS) after occupational exposure to asbestos and silicon.

, 1991
Keiichirou Endou, Masahiro Sugawara, Yoshinari Takasaki, Hiroshi Hashimoto, Shun‐ichi Hirose   +4 more
openalex   +2 more sources

Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study

Rheumatology International, 2011
E. Tinazzi, E. Amelio, Elettra Marangoni, C. Guerra, A. Puccetti, O. Codella, S. Simeoni, E. Cavalieri, M. Montagnana, R. Adani, R. Corrocher, C. Lunardi   +11 more
semanticscholar   +1 more source